Ophthalmology
4 drugs are in development for Geographic Atrophy.
- Companies
- 4
- Clinical trials
- 13
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Geographic Atrophy pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(2)
Preclinical(1)
| Drug | Company |
|---|---|
| pas-nomacopan | Akari Therapeutics Plc (AKTX) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ocu410 | Ocugen, Inc. (OCGN) |
About this indication
Geographic Atrophy context
Ophthalmology·MeSH: Geographic Atrophy (D057092)
Also known as: Atrophies, Geographic, Degeneration, Dry Macular, Degenerations, Dry Macular
Compare drugs
Frequently asked questions
How many drugs are in development for Geographic Atrophy?
BioSniper tracks 4 drugs in development for Geographic Atrophy across 4 companies.
How many clinical trials target Geographic Atrophy?
There are 13 clinical trials targeting Geographic Atrophy tracked by BioSniper.